List of Ministerial briefings
Pharmac publishes the titles of briefings, memos, reports and aides-mémoire to Hon David Seymour, Associate Minister of Health.
On this page
February 2025
|
Date Sent |
Type |
Title |
|---|---|---|
|
19 February 2025 |
Memo |
Ministerial Meeting with Johnson & Johnson |
|
20 February 2025 |
Aide- Mémoire |
Update on Contractual Dispute with Novavax |
|
26 February 2025 |
Report |
Pharmac Consumer Engagement Workshop Report |
|
28 February 2025 |
Report |
Monthly Minister Report |
|
20 February 2025 |
Agenda |
Monthly Minister meeting |
January 2025
No advice was provided in January 2025.
Previous years
|
Date Sent |
Type |
Title |
|---|---|---|
|
5 December |
Information |
Parliament Day Runsheet |
|
6 December |
Memo |
Meeting with Pharmac Interns |
|
6 December |
Report |
Monthly Report for November 2024 |
|
10 December |
Information |
Legal update: Pharmac’s contractual dispute with Novavax |
|
11 December |
Agenda |
December Monthly Meeting |
|
12 December |
Information |
Request for information: End of Year |
|
1 November 2024 |
Memo |
Ministerial Meeting with GSK |
|
4 November 2024 |
Memo |
Ministerial Meeting with Merck Sharp & Dohme |
|
6 November 2024 |
Agenda |
November Monthly Meeting |
|
7 November 2024 |
Memo |
Update: Continuous Glucose Monitor Supply |
|
7 November 2024 |
Report |
Report for Quarter 1 2024/25 |
|
11 November 2024 |
Briefing |
Advice on Assessment and Procurement Processes |
|
13 November |
Briefing |
Advice on Performance Reporting |
|
22 November 2024 |
Memo |
Withheld in full under section 9(2)(f)(iv) of the Official Information Act 1982 |
|
27 November 2025 |
Briefing |
Budget 2025 Update |
|
27 November 2024 |
Talking Points |
Oestradiol Talking Points |
|
28 November 2024 |
Talking Points |
Oestradiol Talking Points |
|
28 November 2024 |
Memo |
Background Information on Tender Decision Oestradiol Patches |
|
1 October 2024 |
Data |
Data on the National Pharmaceutical Purchasing Appropriation |
|
2 October 2024 |
Memo |
Update: Assessment and Decision making – Pilot Programme |
|
3 October 2024 |
Report |
Monthly Report for September 2024 |
|
9 October 2024 |
Agenda |
Monthly Minister Meeting |
|
15 October 2024 |
Memo |
Update: Medical Devices Programme |
|
22 October 2024 |
Statement of Intent |
Draft: Pharmac Statement of Intent 2024/25 – 2027/28 |
|
18 September 2024 |
Agenda |
Monthly Minister Meeting |
|
18 September 2024 |
Aide- mémoire |
ADHD Actions, Dependencies and Milestones |
|
1 August 2024 |
Report |
Report for Quarter 4 2023/24 |
|
9 August 2024 |
Memo |
Pharmacology and Therapeutics Advisory Committee Update |
|
21 August 2024 |
Agenda |
Monthly Minister Meeting |
|
26 August 2024 |
Memo |
Generic Medicine Supply in New Zealand |
|
28 August 2024 |
Report |
Monthly Report for August 2024 |
|
30 August 2024 |
Briefing |
Pharmac assessment and decision making models |
|
16 July 2024 |
Talking points |
Talking points for Min Seymour – Pharmac LOE. |
|
26 July 2024 |
Agenda |
Monthly Minister Meeting |
|
29 July 2024 |
Memo |
Initial discussion – Budget 2025 |
|
4 June 2024 |
Memo |
Background Information relating to 13 Cancer Medicines |
|
7 June 2024 |
Report |
Monthly Report for May 2024 |
|
17 June 2024 |
memo |
Update on Continuous Glucose Monitors Funding Proposal |
|
18 June 2024 |
Agenda |
Monthly Minister Meeting |
|
19 June 2024 |
Memo |
Amended Update on Continuous Glucose Monitors Funding Proposal |
|
19 June 2024 |
Talking Points |
Talking Points for MTANZ 2024 Conference |
|
21 June 2024 |
Memo |
Consumer Advisory Committee Update |
|
21 June 2024 |
Memo |
COVID-19 Treatments |
|
26 June 2024 |
Memo |
Ministerial Meeting with Moderna |
|
26 June 2024 |
Memo |
COVID-19 Vaccines |
|
27 June 2024 |
Report |
Monthly Report for June 2024 |
|
5 May 2024 |
Report |
Report for Quarter 3 2023/24 |
|
6 May 2024 |
Memo |
Ministerial Meeting with AstraZeneca |
|
7 May 2024 |
Memo |
Associate Health Visit Options for Hamilton |
|
14 May 2024 |
Briefing |
Update on Pharmac’s Funding Proposal for Continuous Glucose Monitors and Related Products |
|
20 May 2024 |
Memo |
Ministerial Meeting with AbbVie |
|
21 May 2024 |
Memo |
Additional Information on CGM Consultation |
|
23 May 2024 |
Briefing |
Visit to Pharmac |
|
31 May 2024 |
Memo |
Access to Data |
|
5 April 2024 |
Report |
Monthly Report for March 2024 |
|
12 April 2024 |
Report |
Copy of Board Paper – Supply Issues |
|
24 April 2024 |
Memo |
Ministerial Meeting with Johnson & Johnson (Janssen) |
|
26 April 2024 |
Talking Points |
Draft Talking Points / notes for pre-budget announcement |
|
1 March 2024 |
Report |
Report for Quarter 2 2023/24 |
|
20 March 2024 |
Briefing |
Emerging Therapies Funding Approaches |
|
20 March 2024 |
Briefing |
Funding of myeloma treatments |
|
12 February 2024 |
Memo |
Pharmac’s Hospital Medical Devices Genesis |
|
13 February 2024 |
Briefing |
Consumer Engagement |
|
22 February 2024 |
Briefing |
Ministerial Visit to Pharmac |
|
23 February 2024 |
Briefing |
Parallel Assessment Announcement |
|
23 February 2024 |
Briefing |
Update on Rule 8.1b of the Pharmaceutical Schedule |
|
23 February 2024 |
Memo |
Meeting and Visit Options for Minister in Christchurch |